HDI Publications by date
Search will default to “all years” unless you filter by a specific year below.
Comparison of survival outcomes between dostarlimab and comparator treatments (tx) in patients (pts) with advanced/recurrent (A/R) endometrial cancer (EC) in England
Goulden S, Heffernan K, Nikitas FS, Shukla U, Knott CS, Hunger M, Pahwa A, Schade R. Comparison of survival ...
An overview on synthetic administrative data for research
Theodora Kokosi, Bianca De Stavola, Robin Mitra, Lora Frayling, Aiden Doherty, Iain Dove, Pam Sonnenberg, Katie ...
Short-term mortality in ovarian, fallopian tube ad primary peritoneal carcinomas across England
Ovarian Cancer Audit Feasibility Pilot Steering Group. Short-term mortality in ovarian, fallopian tube ad primary ...
Breast screening atypia and subsequent development of cancer: protocol for an observational analysis of the Sloane database in England (Sloane atypia cohort study).
Jenkinson D, Freeman K, Clements K, Hilton B, Dulson-Cox J, Kearins O, et al.BMJ Open 2022;12: e058050. ...
Unresected screen-detected ductal carcinoma in situ: Outcomes of 311 women in the Forget-Me-Not 2 study.
Maxwell AJ, Hilton B, Clements K, Dodwell D, Dulson-Cox J, Kearins O, et al.The Breast Volume 61, P145-155, ...
Artificial Intelligence in Drug Design: Opportunities and Challenges
Thomas M, Boardman A, Garcia-Ortegon M, Yang H, de Graaf C, Bender AMethods in Molecular Biology (MIMB, volume ...
Demographics and survival outcomes in patients with advanced or recurrent endometrial cancer (EC) following platinum-based doublet (PBD) in the English real-world (RW) setting
Knott CS, Heffernan K, Nikitas FS, Shukla U, Starkie-Camejo H. 812P Demographics and survival outcomes in patients ...
A registry study of relapsed or refractory multiple myeloma pre-exposed to 3 or more therapies including a proteasome inhibitor, an immunomodulatory agent and cd38-targeted monoclonal antibody therapy in England
Elsada A, Zalin-Miller A, Knott CS, Caravotas L. A registry study of relapsed or refractory multiple myeloma ...
Surgical decisions in older women with early breast cancer: patient and disease factors
Jauhari Y, Gannon MR, Dodwell D, Horgan K, Clements K, Medina J, et al.British Journal of Surgery, Volume 108, ...
Significant variation in treatment and survival outcomes in stage 2–4 ovarian cancer in England
Sundar SS, Knott CS, Paley L, et al. Significant variation in treatment and survival outcomes in stage 2–4 ovarian ...
No results found.